Trial Profile
Planned study of NAS 911F in combination with oseltamivir (TamiFlu) in patients with influenza
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs NAS-911 (Primary) ; Oseltamivir
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors New Amsterdam Sciences
- 24 Sep 2014 New trial record
- 06 Aug 2014 A co-therapeutic study of NAS 911F with TamiFlu is planned, according to a New Amsterdam Sciences media release.